Pir Abdul Qadir Shah Jeelani Institute of Medical Sciences, Gambat, Sindh, Pakistan.
Shifa College of Medicine, Islamabad, Pakistan.
Transpl Immunol. 2022 Dec;75:101683. doi: 10.1016/j.trim.2022.101683. Epub 2022 Aug 9.
Over the last decades, liver transplantation (LT) has evolved into a life-saving procedure. Due to limited deceased donor activities in the eastern world, living donor liver transplantation (LDLT) had flourished tremendously in most Asian countries. Yet, these LDLT activities fall short of meeting the expected demands. Pakistan, a developing country, bears a major burden of liver diseases. Currently, only few centers offer LDLT services in the country. On the other hand, deceased donor liver transplantation (DDLT) activities have not started due to social, cultural, and religious beliefs. Various strategies can be adopted successfully to overcome the scarcity of live liver donors (LLDs) and to expand the donor pool, keeping in view donor safety and recipient outcome. These include consideration of LLDs with underlying clinical conditions like G6PD deficiency and Hepatitis B core positivity. Extended donor criteria can also be utilized and relaxation can be made in various donors' parameters including upper age and body mass index after approval from the multidisciplinary board. Also, left lobe grafts, grafts with various anatomical variations, and a low graft-to-recipient ratio can be considered in appropriate situations. ABO-incompatible LT and donor swapping at times may help in expanding the LLDs pool. Similarly, legislation is needed to allow live non-blood-related donors for organ donations. Finally, community education and awareness through various social media flat forms are needed to promote deceased organ donation.
在过去几十年中,肝移植(LT)已发展成为一种挽救生命的手术。由于东方世界已故供体活动有限,活体供体肝移植(LDLT)在大多数亚洲国家得到了迅猛发展。然而,这些 LDLT 活动仍无法满足预期需求。巴基斯坦是一个发展中国家,肝脏疾病负担沉重。目前,该国只有少数几个中心提供 LDLT 服务。另一方面,由于社会、文化和宗教信仰的原因,已故供体肝移植(DDLT)活动尚未开始。可以成功采用各种策略来克服活体肝供体(LLD)的短缺问题,并扩大供体库,同时确保供体安全和受者的治疗效果。这些策略包括考虑有潜在临床疾病(如 G6PD 缺乏症和乙型肝炎核心抗体阳性)的 LLD。也可以利用扩展的供体标准,并在多学科委员会批准后,放宽包括年龄上限和体重指数在内的各种供体参数。此外,在适当情况下可以考虑使用左叶移植物、具有各种解剖变异的移植物和低移植物与受体比例。ABO 不相容的 LT 和供体交换有时可以帮助扩大 LLD 池。同样,需要立法允许活体非血缘关系供体进行器官捐赠。最后,需要通过各种社交媒体平台开展社区教育和宣传,以促进已故器官捐赠。